SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today
announced that Kim Blickenstaff, president and CEO, will present a
company update at the Deutsche Bank 41st Annual Health Care
Conference in Boston, MA. The presentation will take place on Wednesday,
May 4, 2016 at 9:20 AM Eastern Time (6:20 AM Pacific Time).
The presentation will be webcast live, and an archive recording will be
available for 30 days. The link to the live webcast and archive will be
accessible on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com
in the "Investor Events" section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company with an innovative, user-centric and
integrated approach to the design, development and commercialization of
products for people with diabetes who use insulin. The Company
manufactures and sells the t:slim® Insulin Pump, the slimmest and
smallest durable insulin pump currently on the market, the t:flex®
Insulin Pump, the first pump designed for people with greater insulin
requirements, and the t:slim G4™ Insulin Pump, the first continuous
glucose monitoring-enabled pump with touchscreen simplicity. Tandem is
based in San Diego, California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim,
#tslimG4, #tflex, #tconnect, and $TNDM.
Follow Tandem Diabetes Care
on Facebook at www.facebook.com/TandemDiabetes.
Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
t:slim, t:flex, and Tandem Diabetes Care are registered trademarks, and
t:slim G4 is a trademark of Tandem Diabetes Care, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160427006560/en/
Tandem Diabetes Care, Inc.
Susan Morrison, 858-366-6900 x7005
Source: Tandem Diabetes Care, Inc.
News Provided by Acquire Media